Últimos Artículos de Endocrine Related Cancer
- Adrenal-derived factors drive progression of sclerotic prostate cancer in bone
- Molecular determinants of AR–enhancer interaction and cistrome reprogramming in prostate cancer progression
- Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms
- The role of stem cells in pituitary tumour formation
- B7-H3 (CD276) as a candidate therapeutic target in medullary thyroid cancer
- Primary tumor resection in the setting of unresectable metastatic disease in small bowel NETs: consensus and controversy
- Predictive model for the diagnosis of ectopic Cushing syndrome
- The diagnostic value of 68Ga-pentixafor PET/CT in differentiating adrenal aldosterone-producing adenomas from non-functional adenomas
- Orlistat combined with everolimus suppresses pancreatic neuroendocrine tumor progression via inhibiting PI3K/AKT/mTOR signaling mediated by SLFN5
- The secreted protein SPARCL1 suppresses tumor progression in papillary thyroid carcinoma via SLC3A2-mediated ferroptosis
- Single-cell reveals age-dependent epithelial reprogramming and EMT vulnerability in THCA
- Is preoperative adrenoceptor blockade necessary in patients with paraganglioma?
- Mobile elements in pituitary neuroendocrine tumors: integrative evidence and future directions
- Systematic review of the molecular basis for cavernous sinus invasion in somatotropinomas
- Proteomic signatures of adipocyte recruitment in breast cancer
- Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells
- NP-101 in combination with nivolumab and ipilimumab in metastatic extrapulmonary neuroendocrine carcinomas (EP-NECs): A pilot study
- Determinants of false-positive plasma free metanephrines and methoxytyramine: the role of medications and chronic disease
- Unravelling mesenteric fibrosis in small intestinal neuroendocrine tumours and implications for clinical management
- Updating ACC preclinical models: characterization of two new patient-derived cell lines